No Detail Found!

Comparison of the Efficacy of Octreotide Versus Terlipressin in the Prevention of Early Variceal Rebleed after Endoscopic Banding and Ligation.

Author(s)
Asad Sufian Azeem PAC Hospital Kamra, Pakistan
Awais Ali Khan Combined Military Hospital Tarbela, PakistanPAC Hospital Kamra, Pakistan
Sidra Tul Muntaha Combined Military Hospital Abbotabad Pakistan,
Muhammad Tahir PAC Hospital Kamra, Pakistan
Maria Shahzadi Combined Military Hospital /National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Zaeem Ali Khan Riphah International University, Islamabad, Pakistan
Abstract
Objective: To compare the efficacy of terlipressin versus octreotide after endoscopic variceal band ligation (EVL) in prevention of early variceal rebleed. Study Design: Randomized controlled trial. Place and Duration of Study: Department of Gastroenterology, Military Hospital, Rawalpindi, from Jan 2011 to Jun 2011. Material and Method: All patients fulfilling the inclusion criteria were selected through consecutive sampling. Both male and female patients between ages of 30 and 60 years were included in study. All patients received same intravenous antibiotics, intravenous vitamin K, syrup lactulose and underwent upper GI endoscopy with band ligation was done by gastroenterologist. After the procedure, all patients were placed randomly in two groups based on lottery method. Group-A received octreotide and group-B received terlipressin. The group-A received intravenous octreotide at the rate of 50ugm/hour and group-B received terlipressin 1 mg/4 hourly for 5 days after band ligation. Both groups were observed daily for evidence of early rebleed i.e. hematemesis, melena or both. For efficacy to be labelled, both must be absent. End point of the study was the prevention of early rebleed efficiently. Symptoms of hematemesis, melena or both were also recorded in proforma by close monitoring of patient. Results: Efficacy of terlipressin versus octreotide after EVL in prevention of early variceal rebleed was recorded as 87.69% (n=57) in group-A and 96.92% (n=63) in group-B while remaining 12.31% (n=8) in group-A and 3.08% (n=2) in group-B were not effectively treated, p-value was calculated as 0.04 which shows a significant difference in both groups. Conclusion: Terlipressin was significantly more effective than octreotide once combined with EVL in preventing early variceal rebleed in our study.
Publication Details
Page(s) 471-474
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 3, Year: 2018

Request the full text from PASTIC

References
ChenWT,LinCY,SheenIS,HuangCw,LinTN,LinCJ, 2011.MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding,World J Gastroenterol 17 2120 -25
De SouzaAR,La MuraV,ReverterE., 2012.Patients whose first episode of bleeding occurs while taking a β-blocker have high long-term risks of rebleeding and death,Clin Gastroenterol Hepatol 10 670 -76
ThieleM,KragA,RohdeU,GluudLL, 2012.Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices,Aliment Pharmacol Ther 35 1155 -65
MasalaiteL,ValantinasJ,StanaitisJ, 2015.Endoscopic ultrasound findings predict the recurrence of esophageal varices after endoscopic band ligation: A prospective cohort study,Scand J Gastroenterol 50 1322 -
Branch-EllimanW,PerumalswamiP,FactorSH,SeldMS,FlammSL, 2015.Rates of recurrent variceal bleeding are low with modern esophageal banding strategies: A retrospective cohort study,Scand J Gastroenterol 50 1059 -
HwangJH,ShergillAK,AcostaRD,ChandrasekharaV,ChathadiKV,DeckerGA, 2014.The role of endoscopy in the management of varicealhemorrhage,Gastrointest Endosc 80 221 -7
AmitranoL,GuardascioneMA,MangusoF,BennatoR,BoveA,DeNucciC, 2012.The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: Refining shortterm prognosis and risk factors,Am J Gastroenterol 107 1872 -8
XuL,JiF,XuQW,ZhangMQ, 2011.Risk factors for predicting early varicealrebleeding after endoscopic variceal ligation,World J Gastroenterol 17 3347 -52
GrgovS,StamenkovićP, 2011.Does sclerotherapy of remnant little oesophageal varices after endoscopic ligation have impact on the reduction of recurrent varices? Prospective study,Srp Arh Celok Lek 139 328 -32
Wiechowska-KozłowskaA,BiałekA,Raszeja-WyszomirskaJ,StarzyńskaT,MilkiewiczP, 2010.Ligation of oesophageal varices may increase formation of "deep" gastric collaterals,Hepatogastroenterology 57 262 -7
AnsariS,MemonMS,DevrajaniBR, 2009.Frequency of Hepatitis B and Hepatitis C in patients with Hepatocellular carcinoma at Hyderabad,J Liaquat Uni Med Health Sci 8 109 -12
AbidS,JafriW,HamidS,SalihM,AzamZ,MumtazK, 2009.Terlipressin vs Octreotide in bleeding esophageal varices as an adjuvant therapy with endoscpic band ligation: A randomized double blind control placebo controlled trial,Am J Gastroenterol 104 617 -23
LoGH,ChenWC,WangHM,LinCK,ChanHH,TsaiWL, 2009.Low dose terlipressin plus banding ligation versus low dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices,Gut 58 1275 -80
2010.Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension,J Hepatol 53 762 -8
Vieira da RochaEC,D'AmicoEA,CaldwellSH,Flores da RochaTR,SoaresE Silva CS,Dos Santos BomfimV, 2009.A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation,Clin Gastroenterol Hepatol 7 988 -93
NikoloffMA,RileyTR,SchreibmanIR, 2011.Complete esophageal obstruction following endoscopic variceal ligation,Gastroenterol Hepatol (NY) 7 557 -59
0

Citations

0

Downloads

85

Views